Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants.
about
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
P2860
Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@en
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@nl
type
label
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@en
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@nl
prefLabel
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@en
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@nl
P2093
P2860
P356
P1476
Nanoparticles containing siRNA ...... ductive tract tissue explants.
@en
P2093
Alexandra L Howell
Jennifer E Crozier
Nicole O Ilonzo
Stela Celaj
Susan K Eszterhas
P2860
P356
10.4081/IDR.2011.E11
P577
2011-09-07T00:00:00Z